{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T18:08:59Z","timestamp":1784570939936,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-025-02020-0","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:25:25Z","timestamp":1756279525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Beyond blood pressure and glucose: exploring potential biochemical predictors of cardiovascular disease risk in patients with type 2 diabetes mellitus and co-morbid hypertension"],"prefix":"10.1186","volume":"25","author":[{"given":"Bruno","family":"Basil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamila Aminu","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izuchukwu Nnachi","family":"Mba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isiaku Mary","family":"Nkemakolam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blessing Kenechi","family":"Myke-Mbata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"2020_CR1","unstructured":"World Health Organization. Noncommunicable diseases. Geneva WHO. 2024. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/noncommunicable-diseases. Cited 2025 Apr 27."},{"issue":"3","key":"2020_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.23937\/2377-3634\/1410148","volume":"8","author":"ET Emos","year":"2021","unstructured":"Emos ET, Ismaeel Y, Judith HH, Ibrahim AC, Victor BO, Prevalence. Contributing factors and management strategies (Self-Management Education) of type 2 diabetes patients in nigeria: A review. Int J Diabetes Clin Res. 2021;8(3):148. https:\/\/doi.org\/10.23937\/2377-3634\/1410148.","journal-title":"Int J Diabetes Clin Res"},{"key":"2020_CR3","unstructured":"World Health Organization, Regional Office for Africa. African region tops the world in undiagnosed diabetes \u2013 WHO analysis. 2022. Available from: https:\/\/www.afro.who.int\/news\/african-region-tops-world-undiagnosed-diabetes-who-analysis. Cited 2025 Apr 27."},{"issue":"2","key":"2020_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41371-024-00913-6","volume":"39","author":"LF Gafane-Matemane","year":"2025","unstructured":"Gafane-Matemane LF, Craig A, Kruger R, Alaofin OS, Ware LJ, Jones ESW, et al. Hypertension in sub-Saharan africa: the current profile, recent advances, gaps, and priorities. J Hum Hypertens. 2025;39(2):95\u2013110. https:\/\/doi.org\/10.1038\/s41371-024-00913-6.","journal-title":"J Hum Hypertens"},{"issue":"1","key":"2020_CR5","doi-asserted-by":"publisher","first-page":"18892","DOI":"10.1038\/s41598-024-69062-7","volume":"14","author":"A Taheri","year":"2024","unstructured":"Taheri A, Khezri R, Dehghan A, Rezaeian M, Aune D, Rezaei F. Hypertension among persons with type 2 diabetes and its related demographic, socioeconomic and lifestyle factors in the Fasa cohort study. Sci Rep. 2024;14(1):18892. https:\/\/doi.org\/10.1038\/s41598-024-69062-7.","journal-title":"Sci Rep"},{"issue":"1","key":"2020_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12902-025-01930-3","volume":"25","author":"JA Mohammed","year":"2025","unstructured":"Mohammed JA, Basil B, Mba IN, Abubakar ND, Lawal AO, Momoh JA, et al. Elevated high-sensitivity C-reactive protein and dyslipidaemia in type 2 diabetes mellitus: implications for cardiovascular risk prediction in Nigerian patients. BMC Endocr Disord. 2025;25(1):100. https:\/\/doi.org\/10.1186\/s12902-025-01930-3.","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"2020_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-024-01951-9","volume":"9","author":"X Lu","year":"2024","unstructured":"Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng G, et al. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal Transduct Target Ther. 2024;9(1):262. https:\/\/doi.org\/10.1038\/s41392-024-01951-9.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2020_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/antiox14010072","volume":"14","author":"A Caturano","year":"2025","unstructured":"Caturano A, Rocco M, Tagliaferri G, Piacevole A, Nilo D, Di Lorenzo G, et al. Oxidative stress and cardiovascular complications in type 2 diabetes: from pathophysiology to lifestyle modifications. Antioxidants. 2025;14(1):72. https:\/\/doi.org\/10.3390\/antiox14010072.","journal-title":"Antioxidants"},{"issue":"19","key":"2020_CR9","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3390\/cells13191662","volume":"13","author":"V Pellegrini","year":"2024","unstructured":"Pellegrini V, La Grotta R, Carreras F, Giuliani A, Sabbatinelli J, Olivieri F, et al. Inflammatory trajectory of type 2 diabetes: novel opportunities for early and late treatment. Cells. 2024;13(19):1662. https:\/\/doi.org\/10.3390\/cells13191662.","journal-title":"Cells"},{"key":"2020_CR10","doi-asserted-by":"publisher","unstructured":"Basil B, Mohammed JA, Mba IN. Hypertension in Type 2 Diabetes Mellitus: Prevalence, Patterns, Determinants and Implications for cardiovascular risk prediction in Nigerian patients. 2024. PREPRINT (Version 1) available at Research Square [https:\/\/doi.org\/10.21203\/rs.3.rs-5476606\/v1].","DOI":"10.21203\/rs.3.rs-5476606\/v1"},{"issue":"1","key":"2020_CR11","doi-asserted-by":"publisher","first-page":"8775","DOI":"10.1038\/s41598-025-86213-6","volume":"15","author":"M Zhao","year":"2025","unstructured":"Zhao M, Xiao M, Zhang H, Tan Q, Ji J, Cheng Y, et al. Relationship between plasma atherogenic index and incidence of cardiovascular diseases in Chinese middle-aged and elderly people. Sci Rep. 2025;15(1):8775. https:\/\/doi.org\/10.1038\/s41598-025-86213-6.","journal-title":"Sci Rep"},{"issue":"1","key":"2020_CR12","doi-asserted-by":"publisher","first-page":"31092","DOI":"10.1038\/s41598-024-82305-x","volume":"14","author":"Q Zeng","year":"2024","unstructured":"Zeng Q, Zhong Q, Zhao L, An Z, Li S. Combined effect of triglyceride-glucose index and atherogenic index of plasma on cardiovascular disease: a National cohort study. Sci Rep. 2024;14(1):31092. https:\/\/doi.org\/10.1038\/s41598-024-82305-x.","journal-title":"Sci Rep"},{"key":"2020_CR13","doi-asserted-by":"publisher","first-page":"1477419","DOI":"10.3389\/fendo.2024.1477419","volume":"15","author":"J Cao","year":"2025","unstructured":"Cao J, Su Z, Yang J, Zhang B, Jiang R, Lu W, Huang Z, Xie Z. The atherogenic index of plasma is associated with an increased risk of diabetes in non-obese adults: a cohort study. Front Endocrinol. 2025;15:1477419. https:\/\/doi.org\/10.3389\/fendo.2024.1477419.","journal-title":"Front Endocrinol"},{"issue":"9","key":"2020_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s11883-023-01132-z","volume":"25","author":"E D\u0105browska","year":"2023","unstructured":"D\u0105browska E, Narkiewicz K. Hypertension and dyslipidemia: the two partners in Endothelium-Related crime. Curr Atheroscler Rep. 2023;25(9):605\u201312. https:\/\/doi.org\/10.1007\/s11883-023-01132-z.","journal-title":"Curr Atheroscler Rep"},{"issue":"11","key":"2020_CR15","doi-asserted-by":"publisher","first-page":"e032626","DOI":"10.1161\/JAHA.123.032626","volume":"13","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhao S, Huang Y, Ma M, Li B, Li C, et al. Diabetes-Related macrovascular complications are associated with an increased risk of diabetic microvascular complications: A prospective study of 1518 patients with type 1 diabetes and 20 802 patients with type 2 diabetes in the UK biobank. J Am Heart Assoc. 2024;13(11):e032626. https:\/\/doi.org\/10.1161\/JAHA.123.032626.","journal-title":"J Am Heart Assoc"},{"key":"2020_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ijcard.2017.11.082","volume":"254","author":"D Boateng","year":"2018","unstructured":"Boateng D, Agyemang C, Beune E, Meeks K, Smeeth L, Schulze MB, et al. Cardiovascular disease risk prediction in sub-Saharan African populations - Comparative analysis of risk algorithms in the RODAM study. Int J Cardiol. 2018;254:310\u20135. https:\/\/doi.org\/10.1016\/j.ijcard.2017.11.082.","journal-title":"Int J Cardiol"},{"issue":"1","key":"2020_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.60787\/tnhj.v16i1.191","volume":"16","author":"S Ofori","year":"2016","unstructured":"Ofori S, Wachukwu C. Awareness and attitudes towards total cardiovascular disease risk assessment in clinical practice among physicians in Southern Nigeria. Nigerian Health J. 2016;16(1):1\u201312. https:\/\/doi.org\/10.60787\/tnhj.v16i1.191.","journal-title":"Nigerian Health J"},{"issue":"6","key":"2020_CR18","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.numecd.2024.01.026","volume":"34","author":"A Bendera","year":"2024","unstructured":"Bendera A, Nakamura K, Seino K, Alemi S. Performance of the non-laboratory based 2019 WHO cardiovascular disease risk prediction chart in Eastern Sub-Saharan Africa. Nutr Metab Cardiovasc Dis. 2024;34(6):1448\u201355. https:\/\/doi.org\/10.1016\/j.numecd.2024.01.026.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2020_CR19","doi-asserted-by":"publisher","first-page":"111870","DOI":"10.1016\/j.diabres.2024.111870","volume":"217","author":"Y Li","year":"2024","unstructured":"Li Y, Luo J, Bao K, Wei Q, Wang X, Chen J, et al. Association of age at diagnosis of type 2 diabetes mellitus with the risks of the morbidity of cardiovascular disease, cancer and all-cause mortality: evidence from a real-world study with a large population-based cohort study. Diabetes Res Clin Pract. 2024;217:111870. https:\/\/doi.org\/10.1016\/j.diabres.2024.111870.","journal-title":"Diabetes Res Clin Pract"},{"key":"2020_CR20","doi-asserted-by":"publisher","first-page":"e947428","DOI":"10.12659\/MSM.947428","volume":"30","author":"DV Parums","year":"2024","unstructured":"Parums DV, Editorial. The 2024 revision of the declaration of Helsinki and its continued role as a code of ethics to guide medical research. Med Sci Monit. 2024;30:e947428. https:\/\/doi.org\/10.12659\/MSM.947428.","journal-title":"Med Sci Monit"},{"issue":"4","key":"2020_CR21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.4314\/ahs.v23i4.34","volume":"23","author":"OA Adeniyi","year":"2023","unstructured":"Adeniyi OA, Eniade OD, Olarinmoye AT, Abiodun BA, Okedare OO, Eniade AA, et al. Prevalence and associated factors of hypertension among type 2 diabetes mellitus patients in Lautech teaching hospital, osogbo, Nigeria. Afr Health Sci. 2023;23(4):324\u201332.","journal-title":"Afr Health Sci"},{"key":"2020_CR22","doi-asserted-by":"publisher","first-page":"1044638","DOI":"10.3389\/fcvm.2023.1044638","volume":"10","author":"M Kabootari","year":"2023","unstructured":"Kabootari M, Tamehri Zadeh SS, Hasheminia M, Azizi F, Hadaegh F. Change in blood pressure status defined by 2017 ACC\/AHA hypertension guideline and risk of cardiovascular disease: results of over a decade of follow-up of the Iranian population. Front Cardiovasc Med. 2023;10:1044638. https:\/\/doi.org\/10.3389\/fcvm.2023.1044638.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"2020_CR23","doi-asserted-by":"publisher","first-page":"e22119","DOI":"10.7759\/cureus.22119","volume":"14","author":"D Khanna","year":"2022","unstructured":"Khanna D, Peltzer C, Kahar P, Parmar MS. Body mass index (BMI): A screening tool analysis. Cureus. 2022;14(2):e22119. https:\/\/doi.org\/10.7759\/cureus.22119.","journal-title":"Cureus"},{"key":"2020_CR24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.33678\/cor.2022.085","volume":"65","author":"L Askin","year":"2023","unstructured":"Askin L, Tanriverdi O. Is the atherogenic index of plasma (AIP) a cardiovascular disease marker?? Cor Et Vasa. 2023;65:100\u20133.","journal-title":"Cor Et Vasa"},{"key":"2020_CR25","volume-title":"Tietz textbook of clinical chemistry and molecular diagnostics","year":"2018","unstructured":"Wicaksana A, Rachman T, editors. Tietz textbook of clinical chemistry and molecular diagnostics. 6th ed. St. Louis (MO): Elsevier; 2018.","edition":"6"},{"key":"2020_CR26","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1186\/s12872-021-02431-6","volume":"21","author":"H Huang","year":"2021","unstructured":"Huang H, Yu Y, Chen L, Liling C, Shiqun C, Ronghui T, Qiang L, et al. Independent and joint effects of high-sensitivity c-reactive protein and hypoalbuminemia on long-term all-cause mortality among coronary artery disease: a prospective and multi-center cohort study. BMC Cardiovasc Disord. 2021;21:613. https:\/\/doi.org\/10.1186\/s12872-021-02431-6.","journal-title":"BMC Cardiovasc Disord"},{"key":"2020_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4314\/ajbr.v26i1.3","volume":"26","author":"IN Mba","year":"2023","unstructured":"Mba IN, Basil B, Olayanju OA, Okpara IC, Adebisi SA. Serum high sensitivity C-Reactive protein and uric acid as biomarkers of left ventricular hypertrophy in hypertensive patients in makurdi, Nigeria. Afr J Biomed Res. 2023;26:25\u20139. https:\/\/doi.org\/10.4314\/ajbr.v26i1.3.","journal-title":"Afr J Biomed Res"},{"issue":"10","key":"2020_CR28","doi-asserted-by":"publisher","first-page":"e1332","DOI":"10.1016\/S2214-109X(19)30318-3","volume":"7","author":"WHO CVD Risk Chart Working Group","year":"2019","unstructured":"WHO CVD Risk Chart Working Group. World health organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health. 2019;7(10):e1332\u201345. https:\/\/doi.org\/10.1016\/S2214-109X(19)30318-3.","journal-title":"Lancet Glob Health"},{"key":"2020_CR29","doi-asserted-by":"publisher","first-page":"117955142312207","DOI":"10.1177\/11795514231220780","volume":"16","author":"S Chakraborty","year":"2023","unstructured":"Chakraborty S, Verma A, Garg R, Singh J, Verma H. Cardiometabolic risk factors associated with type 2 diabetes mellitus: A mechanistic insight. Clin Med Insights Endocrinol Diabetes. 2023;16:11795514231220780. https:\/\/doi.org\/10.1177\/11795514231220780.","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"2020_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/11795514241263298","volume":"17","author":"EJ Groenewald","year":"2024","unstructured":"Groenewald EJ, Nkambule BB, Nyambuya TM. Aggravated systemic inflammation and atherogenicity in African patients living with type 2 diabetes and hypertension comorbidity. Clin Med Insights Endocrinol Diabetes. 2024;17:1\u20137. https:\/\/doi.org\/10.1177\/11795514241263298.","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"2020_CR31","doi-asserted-by":"publisher","first-page":"1173402","DOI":"10.3389\/fendo.2023.1173402","volume":"14","author":"H Yousef","year":"2023","unstructured":"Yousef H, Khandoker AH, Feng SF, Helf C, Jelinek HF. Inflammation, oxidative stress and mitochondrial dysfunction in the progression of type II diabetes mellitus with coexisting hypertension. Front Endocrinol. 2023;14:1173402. https:\/\/doi.org\/10.3389\/fendo.2023.1173402.","journal-title":"Front Endocrinol"},{"key":"2020_CR32","doi-asserted-by":"publisher","unstructured":"Koziarska-Ro\u015bciszewska M, Gluba-Brz\u00f3zka A, Franczyk B, Rysz J, High-Sensitivity C-R. Protein relationship with metabolic disorders and cardiovascular diseases risk factors. Life (Basel). 2021;11(8). https:\/\/doi.org\/10.3390\/life11080742.","DOI":"10.3390\/life11080742"},{"issue":"1","key":"2020_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12933-020-0989-8","volume":"19","author":"Z Qin","year":"2020","unstructured":"Qin Z, Zhou K, Li Y, Cheng W, Wang Z, Wang J, et al. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19(1):23. https:\/\/doi.org\/10.1186\/s12933-020-0989-8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2020_CR34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12933-023-01979-1","volume":"22","author":"L M\u00e9n\u00e9gaut","year":"2023","unstructured":"M\u00e9n\u00e9gaut L, Laubriet A, Crespy V, Leleu D, Pilot T, Van Dongen K, et al. Inflammation and oxidative stress markers in type 2 diabetes patients with advanced carotid atherosclerosis. Cardiovasc Diabetol. 2023;22(1):248. https:\/\/doi.org\/10.1186\/s12933-023-01979-1.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"2020_CR35","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1515\/cclm-2012-0750","volume":"51","author":"KS Alexander","year":"2013","unstructured":"Alexander KS, Kazmierczak SC, Snyder CK, Oberdorf JA, Farrell DH. Prognostic utility of biochemical markers of cardiovascular risk: impact of biological variability. Clin Chem Lab Med. 2013;51(9):1875\u201382. https:\/\/doi.org\/10.1515\/cclm-2012-0750.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"2020_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12933-016-0418-1","volume":"15","author":"SH Bots","year":"2016","unstructured":"Bots SH, van der Graaf Y, Nathoe HM, de Borst GJ, Kappelle JL, Visseren FL, Westerink J, SMART Study Group. The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease. Cardiovasc Diabetol. 2016;15(1):101. https:\/\/doi.org\/10.1186\/s12933-016-0418-1.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2020_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12933-021-01393-5","volume":"20","author":"L Fu","year":"2021","unstructured":"Fu L, Zhou Y, Sun J, Zhu Z, Xing Z, Zhou S, Wang Y, Tai S. Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2021;20(1):201. https:\/\/doi.org\/10.1186\/s12933-021-01393-5.","journal-title":"Cardiovasc Diabetol"},{"key":"2020_CR38","unstructured":"World Health Organization. Noncommunicable Diseases. 2025. Available from: https:\/\/www.afro.who.int\/health-topics\/noncommunicable-diseases. Cited 2025 Apr 30."},{"issue":"6","key":"2020_CR39","doi-asserted-by":"publisher","first-page":"102557","DOI":"10.1016\/j.cpcardiol.2024.102557","volume":"49","author":"L Alhuneafat","year":"2024","unstructured":"Alhuneafat L, Ta\u2019ani O, Al, Tarawneh T, ElHamdani A, Al-Adayleh R, Al-Ajlouni Y, et al. Burden of cardiovascular disease in Sub-Saharan africa, 1990\u20132019: an analysis of the global burden of disease study. Curr Probl Cardiol. 2024;49(6):102557.","journal-title":"Curr Probl Cardiol"},{"key":"2020_CR40","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. https:\/\/doi.org\/10.1016\/j.diabres.2021.109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"2020_CR41","doi-asserted-by":"publisher","first-page":"100070","DOI":"10.1016\/j.jacadv.2022.100070","volume":"1","author":"P Goyal","year":"2022","unstructured":"Goyal P, Kwak MJ, Al Malouf C, Kumar M, Rohant N, Damluji AA, et al. Geriatric cardiology: coming of age. JACC Adv. 2022;1(3):100070. https:\/\/doi.org\/10.1016\/j.jacadv.2022.100070.","journal-title":"JACC Adv"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02020-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-02020-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-02020-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:50:22Z","timestamp":1757443822000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-025-02020-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2020"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-02020-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6626378\/v1","asserted-by":"object"}]},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted as part of a larger research project approved by the Health Research Ethics Committee of Benue State University Teaching Hospital, Makurdi, under protocol number BSUTH\/CMAC\/HREC\/101\/V.I\/47, dated 21\u2009st January 2019. Ethical conduct was ensured per the principles outlined in the Declaration of Helsinki. Written informed consent was obtained from all participants before enrolment and data collection. To maintain confidentiality, each participant was assigned a unique identification code, and all clinical data and laboratory results were securely stored in restricted areas throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}